chrX-38160939-C-G
Position:
Variant summary
Our verdict is Likely benign. Variant got -4 ACMG points: 0P and 4B. BS2
The NM_006307.5(SRPX):āc.769G>Cā(p.Val257Leu) variant causes a missense change. The variant allele was found at a frequency of 0.000173 in 1,207,793 control chromosomes in the GnomAD database, with no homozygous occurrence. There are 64 hemizygotes in GnomAD. Variant has been reported in ClinVar as Uncertain significance (ā ).
Frequency
Genomes: š 0.000089 ( 0 hom., 1 hem., cov: 22)
Exomes š: 0.00018 ( 0 hom. 63 hem. )
Consequence
SRPX
NM_006307.5 missense
NM_006307.5 missense
Scores
3
9
5
Clinical Significance
Conservation
PhyloP100: 7.06
Genes affected
SRPX (HGNC:11309): (sushi repeat containing protein X-linked) Predicted to be an extracellular matrix structural constituent. Predicted to be involved in cell adhesion. Predicted to act upstream of or within several processes, including negative regulation of cell proliferation involved in contact inhibition; phagolysosome assembly; and positive regulation of extrinsic apoptotic signaling pathway in absence of ligand. Part of collagen-containing extracellular matrix. [provided by Alliance of Genome Resources, Apr 2022]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Likely_benign. Variant got -4 ACMG points.
BS2
High Hemizygotes in GnomAdExome4 at 63 gene
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
SRPX | NM_006307.5 | c.769G>C | p.Val257Leu | missense_variant | 6/10 | ENST00000378533.4 | NP_006298.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
SRPX | ENST00000378533.4 | c.769G>C | p.Val257Leu | missense_variant | 6/10 | 1 | NM_006307.5 | ENSP00000367794 | P2 | |
SRPX | ENST00000544439.5 | c.709G>C | p.Val237Leu | missense_variant | 5/9 | 2 | ENSP00000440758 | A2 | ||
SRPX | ENST00000432886.6 | c.592G>C | p.Val198Leu | missense_variant | 5/9 | 2 | ENSP00000411165 | |||
SRPX | ENST00000538295.5 | c.769G>C | p.Val257Leu | missense_variant | 6/9 | 2 | ENSP00000445034 |
Frequencies
GnomAD3 genomes AF: 0.0000895 AC: 10AN: 111723Hom.: 0 Cov.: 22 AF XY: 0.0000295 AC XY: 1AN XY: 33897
GnomAD3 genomes
AF:
AC:
10
AN:
111723
Hom.:
Cov.:
22
AF XY:
AC XY:
1
AN XY:
33897
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD3 exomes AF: 0.0000657 AC: 12AN: 182683Hom.: 0 AF XY: 0.0000893 AC XY: 6AN XY: 67161
GnomAD3 exomes
AF:
AC:
12
AN:
182683
Hom.:
AF XY:
AC XY:
6
AN XY:
67161
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad SAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.000182 AC: 199AN: 1096016Hom.: 0 Cov.: 29 AF XY: 0.000174 AC XY: 63AN XY: 361474
GnomAD4 exome
AF:
AC:
199
AN:
1096016
Hom.:
Cov.:
29
AF XY:
AC XY:
63
AN XY:
361474
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.0000895 AC: 10AN: 111777Hom.: 0 Cov.: 22 AF XY: 0.0000294 AC XY: 1AN XY: 33961
GnomAD4 genome
AF:
AC:
10
AN:
111777
Hom.:
Cov.:
22
AF XY:
AC XY:
1
AN XY:
33961
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Alfa
AF:
Hom.:
Bravo
AF:
TwinsUK
AF:
AC:
0
ALSPAC
AF:
AC:
1
ESP6500AA
AF:
AC:
0
ESP6500EA
AF:
AC:
1
ExAC
AF:
AC:
14
ClinVar
Significance: Uncertain significance
Submissions summary: Uncertain:1
Revision: criteria provided, single submitter
LINK: link
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Jan 27, 2022 | The c.769G>C (p.V257L) alteration is located in exon 6 (coding exon 6) of the SRPX gene. This alteration results from a G to C substitution at nucleotide position 769, causing the valine (V) at amino acid position 257 to be replaced by a leucine (L). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
AlphaMissense
Pathogenic
BayesDel_addAF
Benign
T
BayesDel_noAF
Benign
CADD
Pathogenic
DANN
Uncertain
DEOGEN2
Benign
.;.;.;T
FATHMM_MKL
Pathogenic
D
LIST_S2
Uncertain
D;D;D;D
M_CAP
Pathogenic
D
MetaRNN
Uncertain
D;D;D;D
MetaSVM
Benign
T
MutationAssessor
Uncertain
.;.;M;M
MutationTaster
Benign
D;D;D;D;D
PrimateAI
Uncertain
T
PROVEAN
Uncertain
D;N;N;N
REVEL
Uncertain
Sift
Uncertain
D;D;D;D
Sift4G
Uncertain
D;D;D;D
Polyphen
1.0
.;.;.;D
Vest4
MutPred
0.87
.;.;Loss of methylation at K256 (P = 0.0387);Loss of methylation at K256 (P = 0.0387);
MVP
MPC
0.16
ClinPred
D
GERP RS
Varity_R
gMVP
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at